Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Stocks are pricey—but there are values to be had. Learn more about our panelists’ picks in this week’s Roundtable installment.

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

U.S. stock futures were marginally higher on Monday night after the S&P 500 and Nasdaq Composite notched a second winning day. S&P 500 futures and Nasdaq 100 futures respectively climbed 0.1% and 0.2% ...

US stocks gave up early gains to end mixed. Investors await key consumer inflation data and the start of earnings season on ...

Asit Sharma: Well, I am chilling with the fam, but in an alternate universe, Ricky, I'm showing up with a few beers and a pack of cards at your house to spend ... drug space after a monster 2022, 2023 ...

A strong Dec. jobs report triggered a $1T market sell-off, highlighting investor fears of rising inflation. Read why I'm ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...

Evercore ISI analyst Umer Raffat maintained a Hold rating on Eli Lilly & Co (LLY – Research Report) yesterday. The company’s shares closed ...